WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, April 11, 2007, 27(15):4201-4209; doi:10.1523/JNEUROSCI.3110-06.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Svenningsson, P.
Right arrow Articles by Greengard, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Svenningsson, P.
Right arrow Articles by Greengard, P.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Biochemical and Behavioral Evidence for Antidepressant-Like Effects of 5-HT6 Receptor Stimulation

Per Svenningsson,1,2 * Eleni T. Tzavara,3,4 * Hongshi Qi,2 Robert Carruthers,1 Jeffrey M. Witkin,3 George G. Nomikos,3 and Paul Greengard1

1Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, New York 10021, 2Department of Physiology and Pharmacology, Karolinska Institute, 171 77 Stockholm, Sweden, 3Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, Indiana 46285, and 4Institut National de la Santé et de la Recherche Médicale U-513, 94010 Créteil, France

Correspondence should be addressed to either of the following: Dr. Paul Greengard, Laboratory of Molecular and Cellular Neuroscience, 1230 York Avenue, The Rockefeller University, New York, NY 10021, Email: greengd{at}mail.rockefeller.edu; or Dr. Per Svenningsson, Department of Physiology and Pharmacology, Nanna Svartz väg 2, Karolinska Institute, 171 77 Stockholm, Sweden, Email: per.svenningsson{at}ki.se

The primary action of several antidepressant treatments used in the clinic raises extracellular concentrations of serotonin (5-HT), which subsequently act on multiple 5-HT receptors. The present study examined whether 5-HT6 receptors might be involved in the antidepressant-like effects mediated by enhanced neurotransmission at 5-HT synapses. A selective 5-HT6 receptor antagonist, SB271046, was evaluated for its ability to counteract fluoxetine-induced biochemical and behavioral responses in mice. In addition, biochemical and behavioral effects of the 5-HT6 receptor agonist, 2-ethyl-5-methoxy-N,N-dimethyltryptamine (EMDT), were assessed in mice to ascertain whether enhancement of 5-HT6 receptor-mediated neurotransmission engenders antidepressant-like effects. SB271046 significantly counteracted the stimulatory actions of fluoxetine on cortical c-fos mRNA, phospho-Ser845-GluR1, and in the tail suspension antidepressant assay, whereas it had no effect on these parameters by itself. EMDT increased the phosphorylation states of Thr34-DARPP-32 and Ser845-GluR1, both in brain slices and in the intact brain, which were effects also seen with the antidepressant fluoxetine; as with fluoxetine, these effects were demonstrated to be independent of D1 receptor stimulation. Systemic administration of EMDT increased c-fos mRNA expression in the striatum and cerebral cortex and reduced immobility in the tail suspension test. The antidepressant-like effects of EMDT in the tail suspension test were prevented by SB271046. Our results indicate that 5-HT6 receptor stimulation may be a mechanism initiating some of the biochemical and behavioral outcomes of 5-HT reuptake inhibitors, such as fluoxetine. These findings also indicate that selective 5-HT6 receptor agonists may represent a novel antidepressant drug class.

Key words: serotonin; antidepressants; fluoxetine; signal transduction; protein phosphorylation; tail suspension test


Received July 21, 2006; revised March 4, 2007; accepted March 6, 2007.

Correspondence should be addressed to either of the following: Dr. Paul Greengard, Laboratory of Molecular and Cellular Neuroscience, 1230 York Avenue, The Rockefeller University, New York, NY 10021, Email: greengd{at}mail.rockefeller.edu; or Dr. Per Svenningsson, Department of Physiology and Pharmacology, Nanna Svartz väg 2, Karolinska Institute, 171 77 Stockholm, Sweden, Email: per.svenningsson{at}ki.se




This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. L. Warner-Schmidt, M. Flajolet, A. Maller, E. Y. Chen, H. Qi, P. Svenningsson, and P. Greengard
Role of p11 in Cellular and Behavioral Effects of 5-HT4 Receptor Stimulation
J. Neurosci., February 11, 2009; 29(6): 1937 - 1946.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-